Message from TBSF President | Sustainability | Taiwan Blood Services Foundation ESG
Message from TBSF President


For more than five decades since its establishment, the Taiwan Blood Services Foundation has always shouldered the important responsibility of safeguarding national blood safety. We have not only built an internationally recognized voluntary non-remunerated blood donation system, but have also made Taiwan one of the few countries in the world that has long maintained self-sufficiency in blood supply. This achievement is not the result of any single institution, but of the social trust collectively built by the government, medical institutions, enterprises, volunteers, and millions of blood donors. As Chairman of the Taiwan Blood Services Foundation, I have always been thinking about how to carry this trust forward and transform it into a sustainable governance commitment for the future.
In July 2022, the Taiwan Blood Services Foundation published its first sustainability report, the 2021 Sustainability Report, responding to the United Nations Sustainable Development Goals (SDGs) through concrete action. That same year, the Foundation received the Silver Award in the “Corporate Sustainability Report Category—Government and NGO Group—Category 2” at the Taiwan Corporate Sustainability Awards. In September 2024, the Foundation published the 2023 Sustainability Report and once again received recognition, winning the Gold Award in the “Corporate Sustainability Report Category—Government and NGO Group—Category 2.” This represents the Foundation’s spirit of pursuing excellence in quality and sustainable governance—being good, and striving to be even better!
Today, the Taiwan Blood Services Foundation continues to build on this momentum. With reference to various international standards, including GRI, AA1000, SDGs, TCFD, SASB, TNFD, and IFRS Sustainability Disclosure Standards S1 and S2, the 2025 Sustainability Report demonstrates the achievements and determination of Taiwan’s blood services to keep pace with the times across areas such as integrity governance, digital transformation, environmental sustainability, social sustainability, and international alignment. Looking back over the past two years, we have continued to strengthen governance effectiveness, embed sustainability concepts into every decision, and further enhance Taiwan’s medical resilience.
Society is changing, but what remains unchanged is that the Taiwan Blood Services Foundation has always regarded ESG as an important strategy for the Foundation’s sustainable governance. E stands for Environmental protection, reducing the environmental impact of blood services through low-carbon operations, circular use, and energy-saving management. S stands for Social responsibility, safeguarding blood safety for all people, deepening public welfare participation, and promoting intergenerational continuity. G stands for corporate and organizational Governance, establishing a transparent, ethical, responsible, and forward-looking management system to respond to social expectations and create long-term public value.
In recent years, the global landscape has changed rapidly. Extreme weather, major natural disasters, pandemic impacts, population aging, declining birthrates, and the restructuring of international supply chains have all brought unprecedented challenges to healthcare systems. Countries around the world have also gradually come to realize that true medical resilience does not lie in rapid response after a crisis occurs, but in comprehensive preparedness in systems, talent, materials, and technology during normal times.
Therefore, we have actively promoted foundational projects to strengthen the medical resilience of the blood donation and supply system. These include increasing the safe inventory of blood bags, supporting domestically produced blood bags to strengthen supply chain autonomy, building a national blood data governance platform, promoting smart decision-making, improving information security protection, establishing cross-regional dispatch mechanisms, and developing innovative applications such as low-titer group O whole blood, in-hospital emergency blood collection, and drone blood delivery. These efforts share one common goal—to ensure that Taiwan can maintain a safe, stable, and uninterrupted blood supply under any circumstances.
Equally important, the Foundation continues to promote low-carbon transformation and the circular economy. We have actively introduced electric bloodmobiles, implemented energy conservation and carbon reduction goals, and designed a solar photovoltaic energy storage system on the rooftop of the Annan Blood Component Manufacturing Site, which opened in June 2026. We have also promoted the reuse of surplus plasma and the resource recovery of medical waste, allowing the public welfare mission of saving lives and environmental sustainability to reinforce one another. We believe that safeguarding lives and protecting the Earth are not in conflict, but are shared responsibilities of medical institutions.
However, it must be acknowledged that a stable blood source requires participation and continuity from generation to generation. Facing the dual challenges of Taiwan’s rapidly aging society and declining birthrate, the Foundation has actively organized promotional campaigns and blood donation activities at universities, colleges, senior high schools, and vocational high schools across the country. Through diverse outreach efforts, we are proactively cultivating blood donation awareness among younger generations. Therefore, the Taiwan Blood Services Foundation is also taking root through science publications and campus education, with the hope of fostering the next generation’s identification with blood donation as a public welfare cause and jointly carrying forward this warm current of social compassion.
It is worth mentioning that in recent years, the Taiwan Blood Services Foundation has continued to deepen international cooperation and exchange, and has actively participated in global blood professional organizations. In December 2025, the Executive Committee of the International Plasma and Fractionation Association (IPFA) officially approved the Foundation’s membership application, making Taiwan the second blood organization in Asia, after Japan, to be approved for IPFA membership. This honor represents international recognition of Taiwan’s blood manufacturing capabilities and quality management standards, and is also a concrete achievement of the Foundation’s years of continuous improvement and implementation of the “national blood for national use” policy.
Health is the most fundamental right of the people; a stable, safe, and sufficient blood supply is an indispensable pillar of national resilient healthcare. The Taiwan Blood Services Foundation actively shoulders the vital responsibility of safeguarding the lives and safety of the people. Maintaining the safety and resilience of this system is not only the mission of the Taiwan Blood Services Foundation, but also an important foundation for realizing a “Healthy Taiwan.” Looking ahead, we will continue to uphold the principles of “blood product safety × social justice × environmental sustainability,” enabling Taiwan not only to become a model of blood safety in Asia, but also a benchmark for advancing sustainable healthcare.